Michel Boisbrun

922 citations

40 papers · 767 indexed · h-index 19

Organic Chemistry top 5%
- Chemical synthesis and alkaloids 6
Pharmacology top 5%
- Alkaloids: synthesis and pharmacology 5
Pharmacology top 10%
- Alkaloids: synthesis and pharmacology 5
Toxicology top 10%
Cancer Research
- Cancer, Lipids, and Metabolism 4
- Cancer, Hypoxia, and Metabolism 3
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 11
- Metabolism, Diabetes, and Cancer 5
- Synthesis and bioactivity of alkaloids 3
Clinical Psychology
- Psychedelics and Drug Studies 4

Co-authors: Yves Chapleur Stéphane Flament Isabelle Grillier‐Vuissoz Sabine Mazerbourg Sandra Kuntz János Sápi Jean‐Yves Laronze Dominique Laurain‐Mattar
Cited by: Organic Chemistry Pharmacology
Partner nations: France Poland South Korea

In The Last Decade

Michel Boisbrun

40 papers receiving 758 citations

Peers

Countries citing papers authored by Michel Boisbrun

Since Specialization

Citations

This map shows the geographic impact of Michel Boisbrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Boisbrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Boisbrun more than expected).

Fields of papers citing papers by Michel Boisbrun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Boisbrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Boisbrun. The network helps show where Michel Boisbrun may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michel Boisbrun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel Boisbrun Line = papers co-authored together Michel Boisbrun links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors Claire Muller,Victorine Lacroix-Malgras,Jérôme Kluza,William Laine,Yonca Güler,Frédéric Bost,Michel Boisbrun,Sabine Mazerbourg,Stéphane Flament	2024	2
2	Unexplored Vinylic-Substituted 5-Benzylidenethiazolidine-2,4-diones: Synthesis and DFT/NMR Stereochemical Assignment Dorian Dupommier,Michel Boisbrun,Gérald Monard,Corinne Comoy	2023	1
3	Characterization of Biological Properties of Individual Phenolamides and Phenolamide-Enriched Leaf Tomato Extracts Marwa Roumani,Armelle Ropars,Christophe Robin,Raphaël E. Duval,Jean‐Pol Frippiat,Michel Boisbrun,Romain Larbat	2023	5
4	AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin Marine Geoffroy,Marine Lemesle,Alexandra Kleinclauss,Sabine Mazerbourg,Levy Batista,Muriel Barberi-Heyob,Thierry Bastogne,Wilfrid Boireau,Alain Rouleau,Dorian Dupommier,Michel Boisbrun,Corinne Comoy,Stéphane Flament,Isabelle Grillier‐Vuissoz,Sandra Kuntz	2022	3
5	Transcriptomics and Metabolomics Analyses Reveal High Induction of the Phenolamide Pathway in Tomato Plants Attacked by the Leafminer Tuta absoluta Marwa Roumani,Jacques Le Bot,Michel Boisbrun,Florent Magot,Arthur Péré,Christophe Robin,Frédérique Hilliou,Romain Larbat	2022	19
6	New desulfured troglitazone derivatives: Improved synthesis and biological evaluation Dorian Dupommier,Claire Muller,Corinne Comoy,Sabine Mazerbourg,Andrea Bordessa,Eline Piquard,Manon Pawlak,Flavian Piquard,Hélène Martin,Elia de Fays,Stéphanie Grandemange,Stéphane Flament,Michel Boisbrun	2019	7
7	Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1 Marine Geoffroy,Alexandra Kleinclauss,Stéphanie Grandemange,Sébastien Hupont,Michel Boisbrun,Stéphane Flament,Isabelle Grillier‐Vuissoz,Sandra Kuntz	2017	6
8	Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment? Sabine Mazerbourg,Sandra Kuntz,Isabelle Grillier‐Vuissoz,Audrey Berthe,Marine Geoffroy,Stéphane Flament,Andrea Bordessa,Michel Boisbrun	2016	10
9	Optimization of troglitazone derivatives as potent anti-proliferative agents: Towards more active and less toxic compounds Andrea Bordessa,Christelle Colin,Isabelle Grillier‐Vuissoz,Sandra Kuntz,Sabine Mazerbourg,Gauthier Husson,Myriam Vo,Stéphane Flament,Hélène Martin,Yves Chapleur,Michel Boisbrun	2014	26
10	Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones Sandra Kuntz,Sabine Mazerbourg,Michel Boisbrun,Claudia Cerella,Marc Diederich,Isabelle Grillier‐Vuissoz,Stéphane Flament	2014	21
11	From d-glucuronic acid to l-iduronic acid derivatives via a radical tandem decarboxylation–cyclization Stéphane Salamone,Michel Boisbrun,Claude Didierjean,Yves Chapleur	2014	9
12	Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study Stéphane Salamone,Christelle Colin,Isabelle Grillier‐Vuissoz,Sandra Kuntz,Sabine Mazerbourg,Stéphane Flament,Hélène Martin,Lysiane Richert,Yves Chapleur,Michel Boisbrun	2012	57
13	Structure-Activity Relationships and Drug Allergy Frédéric Hasdenteufel,Samuel Luyasu,Nicolas Hougardy,M. McD. Fisher,Michel Boisbrun,Paul‐Michel Mertès,Gisèle Kanny	2012	28
14	EGR1 expression: A calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells Sarra Chbicheb,Yao Xiao,Jean‐Luc Rodeau,Stéphane Salamone,Michel Boisbrun,Gerald Thiel,Daniel Spohn,Isabelle Grillier‐Vuissoz,Yves Chapleur,Stéphane Flament,Sabine Mazerbourg	2011	17
15	New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines Christelle Colin,Stéphane Salamone,Isabelle Grillier‐Vuissoz,Michel Boisbrun,Sandra Kuntz,Julie Lecomte,Yves Chapleur,Stéphane Flament	2010	22
16	Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials Sergio Caldarelli,Michel Boisbrun,Karine Alarcon,Abdallah Hamzé,Mahama Ouattara,Xavier J. Salom‐Roig,Marjorie Maynadier,Sharon Wein,Suzanne Peyrottes,Alain Pellet,Michèle Calas,Henri Vial	2010	14
17	Disruption of ERα signalling pathway by PPARγ agonists: evidences of PPARγ-independent events in two hormone-dependent breast cancer cell lines Julie Lecomte,Stéphane Flament,Stéphane Salamone,Michel Boisbrun,Sabine Mazerbourg,Yves Chapleur,Isabelle Grillier‐Vuissoz	2008	31
18	Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-β-carbolines Marie Laronze,Michel Boisbrun,Stéphane Léonce,Bruno Pfeiffer,Pierre‐Yves Renard,Olivier Lozach,Laurent Meijer,A Lansiaux,Christian Bailly,János Sápi,J.‐Y. LARONZE	2005	74
19	Multicomponent approach for the synthesis of non-natural tryptophan, tryptamine and β-carboline derivatives Laurent Jeannin,Michel Boisbrun,Csaba Nemes,Fabien Cochard,Marie Laronze,Emmanuel Dardennes,Árpád Kovács-Kulyassa,János Sápi,Jean‐Yves Laronze	2003	17
20	BACE1- and BACE2-expressing Human Cells David Andrau,Cécile Dumanchin‐Njock,Erwan Ayral,Jean Vizzavona,Michael Farzan,Michel Boisbrun,Pierre Fulcrand,Jean‐François Hernandez,Jean Martínez,Solveig Lefranc‐Jullien,Frédéric Checler	2003	61

About Michel Boisbrun

Michel Boisbrun is a scholar working on Pharmacology, Organic Chemistry and Cancer Research, having authored 40 papers that have together received 767 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (11 papers), Chemical synthesis and alkaloids (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Alkaloids: synthesis and pharmacology (5 papers), Psychedelics and Drug Studies (4 papers), Cancer, Lipids, and Metabolism (4 papers), Synthesis and bioactivity of alkaloids (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Organic Chemistry (397 citations), Pharmacology (82 citations) and Pharmacology (120 citations). Michel Boisbrun has collaborated with scholars based in France, Poland and South Korea. Frequent co-authors include Yves Chapleur, Stéphane Flament, Isabelle Grillier‐Vuissoz, Sabine Mazerbourg, Sandra Kuntz, János Sápi, Jean‐Yves Laronze, Dominique Laurain‐Mattar, Agata Ptak and François Dupire.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact